A retrospective study of the indications for the use of interferon gamma release assays (IGRA) in a United Kingdom (UK) district general hospital (DGH) tuberculosis (TB) clinic Source: International Congress 2015 – Screening strategies in TB Year: 2015
Implementing an IGRA (interferon-gamma release assay) based TB screening pathway prior to starting biological treatments – Experience from a UK university hospital Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Use of interferon-gamma release assays in diagnosis of active TB infection - Experience of a rural UK hospital Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013
The changing indications for IGRA testing and impact on TB services in a UK district general hospital Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013
Serial QuantiFERON TB-2G testing for 4 years of health care workers in a city hospital Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013
Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015
A prospective longitudinal study evaluating a T-cell-based assay for latent tuberculosis infection in healthcare workers in a general hospital in Beijing Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013
Cross sectional screening of health care workers (HCW) at a regional chest clinic with an interferon gamma release assay (IGRA): First report from Sri Lanka Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
Utility of a T-cell interferon-gamma release assay for the diagnosis of tuberculous serositis: A prospective study in Beijing, China Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015
Tuberculin skin test (TST) conversions rates, its relationship with interferon gamma release assay and safety and efficacy of 4 months rifampicin therapy (4R) for latent TB infection (LTBI) among nursing students in south India Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010
An audit of diagnosis and chemoprophylaxis treatment of latent tuberculosis Infection (LTBI) in TB contact patients in a district general hospital (DGH) in the United Kingdom (UK) Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010
Effectiveness of mandatory treatment for tuberculosis - An observational registry study Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
Cytokine profiling of specific T cells in patients after BCG-therapy allows distinction between patients with primary infection and prior contact Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013
Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Diagnosis of latent tuberculosis infection in children with the useof different immunological methods Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Impact of interferon-? release assay on the latent tuberculosis cascade of care: a population-based study Source: Eur Respir J , 49 (3) 1601546; DOI: 10.1183/13993003.01546-2016 Year: 2017
Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016